These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25191656)

  • 21. CD30+ cells in regressing keratoacanthoma and in non-keratoacanthomatous squamous cell carcinoma.
    Fernandez-Flores A
    Bratisl Lek Listy; 2008; 109(11):508-12. PubMed ID: 19205562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferating cell nuclear antigen (PCNA) expression in pseudoepitheliomatous hyperplasia, keratoacanthoma and squamous cell carcinoma of the skin.
    Li J; Lee YS
    Ann Acad Med Singap; 1996 Jul; 25(4):526-30. PubMed ID: 8893923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases.
    Cribier B; Asch P; Grosshans E
    Dermatology; 1999; 199(3):208-12. PubMed ID: 10592399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
    Phillips P; Helm KF
    J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasal vestibular huge keratoacanthoma: an unusual site.
    Yazdani N; Khorsandi-Ashtiani M; Rabbani-Anari M; Bassam A; Kouhi A
    Pak J Biol Sci; 2009 Oct; 12(20):1385-7. PubMed ID: 20128508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What Is a Solitary Keratoacanthoma? A Benign Follicular Neoplasm, Frequently Associated with Squamous Cell Carcinoma.
    Ogita A; Ansai SI
    Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of p53, Ki-67 and laminin expression in the differential diagnosis of keratoacanthoma and well-differentiated SCC.
    Turan G; Altun E; Aslan F; Kulahci O
    Indian J Pathol Microbiol; 2019; 62(4):561-565. PubMed ID: 31611440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Giant keratoacanthoma of the lower lip: case report and review of the published literature.
    Guimarães EP; de Carli ML; Sperandio FF; Pereira AA; Hanemann JA
    Gen Dent; 2016; 64(1):22-5. PubMed ID: 26742162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cutaneous CD30+ anaplastic large-cell lymphomas mimicking keratoacanthomas.
    Martín JM; Ricart JM; Monteagudo C; Alcácer J; Pinazo I; Tomás L; Rausell N; Jordá E
    Clin Exp Dermatol; 2007 Nov; 32(6):668-71. PubMed ID: 17953637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keratoacanthoma versus invasive squamous cell carcinoma: a comparison of dermatoscopic vascular features in 510 cases.
    Pyne JH; Windrum G; Sapkota D; Wong JC
    Dermatol Pract Concept; 2014 Jul; 4(3):37-41. PubMed ID: 25126456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy for keratoacanthoma on the upper lip.
    Liang X; Lin S; Yan J
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101798. PubMed ID: 32360853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in-situ hybridization.
    Cheville JC; Bromley C; Argenyi ZB
    J Cutan Pathol; 1995 Dec; 22(6):546-50. PubMed ID: 8835173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, histopathological and immunohistochemical study of keratoacanthoma.
    Vîlcea AM; Stoica LE; Georgescu CV; Popescu FC; Ciurea RN; Vîlcea ID; Mirea CS
    Rom J Morphol Embryol; 2021; 62(2):445-456. PubMed ID: 35024732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological study of crateriform verruca: Crateriform epithelial lesions histopathologically distinct from keratoacanthoma.
    Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
    J Dermatol; 2016 Oct; 43(10):1154-1159. PubMed ID: 26970425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha.
    Cabrijan L; Lipozencić J; Batinac T; Lenković M; Zgombić ZS
    Coll Antropol; 2013 Mar; 37(1):147-50. PubMed ID: 23697265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
    Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keratoacanthoma of the conjunctiva - case report and review of the literature.
    Szabo BA; Şovrea AS; Bartoş DM; Bartoş A; Georgiu C
    Rom J Morphol Embryol; 2017; 58(4):1605-1609. PubMed ID: 29556663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers.
    Slater M; Barden JA
    Histopathology; 2005 Aug; 47(2):170-8. PubMed ID: 16045778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and follow-up of keratoacanthoma-like lesions: clinical-histologic study of 43 cases.
    Magalhães RF; Cruvinel GT; Cintra GF; Cintra ML; Ismael AP; de Moraes AM
    J Cutan Med Surg; 2008; 12(4):163-73. PubMed ID: 18627696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.